Overview

CHR provides strategic decision support for life-science clients, with Solici handling strategic competitive intelligence and Vox.Bio handling market research, plus a Pricing & Market Access team. Its approach combines hypothesis-driven strategy consulting with iterative research and landscape assessments to deliver evidence-based recommendations for product strategy, commercialization, and portfolio planning. It differentiates itself through a house-of-brands model that unpacks services into focused divisions, a global network with offices in Cambridge and London and consultants across multiple regions, and a proven track record including the Queen’s Award for Enterprise. The goal is to help clients understand market dynamics, regulatory and payer perspectives, and other market forces to guide decisions from development through product lifecycle and improve commercial outcomes.